ARVEE

Arvee Laboratories (India) Share Price

₹174.16 +4.33 (2.55%)

05 Nov, 2024 16:50

SIP TrendupStart SIP in ARVEE

Start SIP

Performance

  • Low
  • ₹172
  • High
  • ₹178
  • 52 Week Low
  • ₹110
  • 52 Week High
  • ₹315
  • Open Price₹172
  • Previous Close₹170
  • Volume1,851

Investment Returns

  • Over 1 Month -4.94%
  • Over 3 Month -5.81%
  • Over 6 Month -18.52%
  • Over 1 Year + 50.01%
SIP Lightning

Smart Investing Starts Here Start SIP with Arvee Laboratories (India) for Steady Growth!

Arvee Laboratories (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 127.4
  • PEG Ratio
  • -2.3
  • Market Cap Cr
  • 192
  • P/B Ratio
  • 6.6
  • Average True Range
  • 14.64
  • EPS
  • 0.9
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.4
  • RSI
  • 45.09
  • MFI
  • 80.88

Arvee Laboratories (India) Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations10.606.147.708.917.60
Total Income From Operations10.606.147.708.917.60
P/L Before Interest, Excpt. Items & Tax1.340.630.360.360.72
P/L Before Exceptional Items & Tax1.260.580.320.280.65
P/L After Tax from Ordinary Activities0.940.120.240.210.49
Net Profit/Loss For the Period0.940.120.240.210.49
IndicatorMar 24Mar 23
Revenue From Operations [Gross]30.3461.28
Revenue From Operations [Net]30.3461.28
Total Operating Revenues30.3561.35
Total Revenue30.9962.70
Total Expenses29.1656.53
Profit/Loss Before Tax1.836.17
Profit/Loss For The Period1.054.12
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity3.662.93
Net Cash Used In Investing Activity-2.16-1.26
Net Cash Used in Finance Activity-0.19-2.42
Net Inc/Dec In Cash And Equivalent1.31-0.75
Cash And Equivalent End Of Year1.850.54
IndicatorMar 24Mar 23
Total Share Capital11.0211.02
Total Non-Current Liabilities2.141.78
Total Current Liabilities6.948.84
Total Capital And Liabilities38.2038.69
Total Non-Current Assets21.4117.12
Total Current Assets16.7921.57
Total Assets38.2038.69
Indicator20242023
EBIT Margin (%)6.8510.68
Return On Capital Employed (%)6.6521.95
Return On Equity (%)3.6114.67
Long Term Debt To Equity (%)3.433.56
Book Value/Share (INR)26.4225.46
Indicator20242023
EBIT Margin (%)6.8510.68
Return On Capital Employed (%)6.6521.95
Return On Equity (%)3.6114.67
Long Term Debt To Equity (%)3.433.56
Book Value/Share (INR)26.4225.46

Arvee Laboratories (India) Technicals

EMA & SMA

Current Price
₹174.16
+ 4.33 (2.55%)
pointer
  • stock-down_img
  • Bullish Moving Average 2
  • stock-up_img
  • Bearish Moving Average 14
  • 20 Day
  • ₹178.17
  • 50 Day
  • ₹180.92
  • 100 Day
  • ₹181.64
  • 200 Day
  • ₹174.87

Resistance and Support

171.96 Pivot Speed
  • R3 193.29
  • R2 186.89
  • R1 178.36
  • S1 163.43
  • S2 157.03
  • S3 148.50

Is Arvee Laboratories (India) Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Arvee Laboratories (India) has an operating revenue of Rs. 33.35 Cr. on a trailing 12-month basis. An annual revenue de-growth of -51% needs improvement, Pre-tax margin of 6% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 79 which is a FAIR score but needs to improve its earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 70 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Arvee Laboratories (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-13 Quarterly Results
2024-02-13 Quarterly Results (Revised) issue in the ratio of 1:1 of Rs. 10/-.
2023-11-07 Quarterly Results
2023-08-11 Quarterly Results
2023-05-05 Audited Results

Arvee Laboratories (India) F&O

Arvee Laboratories (India) Shareholding Pattern

73.5%
26.34%
0.16%
  • NSE Symbol
  • ARVEE
  • BSE Symbol
  • Managing Director
  • Mr. Shalin Sudhakarbhai Patel
  • ISIN
  • INE006Z01016

Arvee Laboratories (India) FAQs

Arvee Laboratories (India) share price is ₹174 As on 05 November, 2024 | 16:36

The Market Cap of Arvee Laboratories (India) is ₹191.9 Cr As on 05 November, 2024 | 16:36

The P/E ratio of Arvee Laboratories (India) is 127.4 As on 05 November, 2024 | 16:36

The PB ratio of Arvee Laboratories (India) is 6.6 As on 05 November, 2024 | 16:36

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form